Athenex Pharmaceutical Launches Levothyroxine Sodium for Injection

Athenex announced the launch of Levothyroxine Sodium for Injection through its subsidiary Athenex Pharmaceutical Division (APD). The APD product was brought to market in close cooperation with Princeton, NJ-based development partner, MAIA Pharmaceuticals.

APD is focused on supplying the US hospital market with high-quality specialty injectable products that address unmet or underserved hospital needs, including high-volume, niche and/or shortage products.

Levothyroxine Sodium for Injection products available to order from Athenex include:

• 100 mcg per vial
• 200 mcg per vial
• 500 mcg per vial

Per IQVIA sales data, the Levothyroxine Sodium for Injection market in the United States exceeds $85 million annually.

"We are delighted to introduce multiple SKUs of Levothyroxine Sodium Injection to the US hospital market. Our launch of Levothyroxine demonstrates the unique ability of Athenex to work quickly and collaboratively to bring needed products to our customers," Jeffrey Yordon, Athenex’s Chief Operating Officer and President of APD, said. "We’d like to thank our partners at MAIA for matching our agility, enabling our speed to market and supporting our unwavering commitment to delivering high-quality products that can help address our customers’ ongoing needs."

"We are thrilled with the FDA approval of MAIA’s third product and are honored to work with a seasoned and exceptional team at Athenex to bring Levothyroxine Sodium for Injection to the US market leveraging their unique cross-functional capabilities across both specialty and generic medicines," Bikram Malik, MAIA, said. "They are the best in the business. Levothyroxine is the first of what we hope to be many future product collaborations with Athenex."

Athenex’s products emphasize quality and can help to enhance patient safety. Athenex’s AccuraSEE Packaging and Labeling, a proprietary, patent-pending and highly differentiated approach to product packaging and labeling, features a unique label design for every product to give caregivers accurate information and help to reduce the risk of medication errors.

-----------------------------------------------------------------------

Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.